Safety Study of Subcutaneously Administered PL-3994 in Subjects With Controlled Hypertension

Summary

The objective of this study is to evaluate the safety, tolerability, and pharmacokinetics of subcutaneous (SC) PL-3994, relative to placebo in subjects with controlled hypertension. Including in this evaluation is the effect PL3994 has on blood pressure.

Timeline

Start

2008-04

Primary completion

2008-07

Completion

2008-07

Drugs

Indications